Stock analysts at StockNews.com started coverage on shares of Check-Cap (NASDAQ:CHEK – Get Free Report) in a research report issued to clients and investors on Monday. The firm set a “sell” rating on the medical research company’s stock. Check-Cap Price Performance Shares of NASDAQ CHEK opened at $2.25 on Monday. Check-Cap has a one year […]